Home > Insider Trading > Filing (0000911916-16-000596)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1348649	Colucid Pharmaceuticals Inc.	CLCD	Pharmaceutical Preparations (2834)	203419541

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1658550	Raymond Skwierczynski	C/O Colucid Pharmaceuticals, Inc. 222 Third Street Cambridge MA 02142	Head,Pharmaceutical Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-06-10	508	$6.60	3,753	No	4	S	Direct
Common Stock	Disposition	2016-06-20	500	$7.00	3,253	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Mr. Skwierczynski on June 1, 2016.
Represents the sale of 508 shares in multiple transactions, ranging in price from $6.60 to $6.5001 per share, resulting in a weighted average sale price of $6.5984. The reporting person will provide, upon request bythe SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
Includes 4,261 shares acquired under the CoLucid Pharmaceuticals, Inc. Employee Stock Purchase Plan between December 1, 2015 and May 31, 2016 of which 508 shares were sold on June 10, 2016.